Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C - A randomized trial

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Rusu, Emilia ^a,b,c   Jinga, Mariana ^b,d   Enache, Georgiana ^a   Rusu, Florin ^c,d   Dragomir, Andreea Diana ^b,c   Ancuta, Ioan ^b,e   Draguţ, Ramona ^a,b   Parpala, Cristina ^a   Nan, Raluca ^a,b   Sima, Irina ^a   Ateia, Simona ^b   Stoica, Victor ^c,e   Cheţa, Dan Mircea ^a,b,c   Radulian, Gabriela ^a,b,c  

^a N Paulescu National Institute of Diabetes Nutrition and Metabolic Diseases   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Healthy Nutrition Foundation   (Romania)

^d Carol Davila Central Military Emergency Hospital   (Romania)

^e CANTACUZINO INSTITUTE   (Romania)

Author keywords

Body mass index; Diet; Hepatitis C; HOMA IR; Lifestyle change

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; DIETARY INTAKE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIVER FIBROSIS; LOW CALORY DIET; LOW FAT DIET; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; NORMOGLUCIDIC LOW CALORIE DIET; OBESITY; PATIENT CARE; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SEDENTARY LIFESTYLE; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CONTROL; WEIGHT REDUCTION;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; CALORIC RESTRICTION; CHOLESTEROL; DIET, FAT-RESTRICTED; ENDPOINT DETERMINATION; ENERGY INTAKE; FATTY LIVER; FEMALE; FOOD HABITS; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C, CHRONIC; HUMANS; INSULIN RESISTANCE; INTERVENTION STUDIES; LIFE STYLE; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84882772125     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-119     Document Type: Article

References (40)

1. Epidemiology of Hepatitis B and C Viruses: A global overview. Helen ST, Jensen MD, Clin Liver Dis 2010 14 1 21 10.1016/j.cld.2009.11.009 20123436
2. Effectiveness and tolerability of pegylated Interferon alpha-2a and ribavirin combination therapy in Romanian patients with chronic hepatitis C: from clinical trials to clinical practice. Gheorghe L, Grigorescu M, Iacob S, Damian D, Gheorghe C, Iacob R, Simionov I, Vadan R, Parvulescu I, Bancila I, Rom J Gastroenterol 2005 14 109 115 15990928 (Pubitemid 40933477)
3. Hepatitis C and cardiovascular risk: facts and controversies. Lonardo A, Ballestri S, Restivo L, Adinolfi L, Loria P, Hot Topics In Viral Hepatitis 2012 24 27 35
4. World Health Organization, Obesity: preventing and managing the global epidemic: report of a World Health Organization Consultation Geneva, Switzerland: World Health Organization 1997
5. The National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J, JAMA 2002 88 1882 1888 (Pubitemid 35168144)
6. Estimatión of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 6 499 502 4337382
7. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
8. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus Geneva 1999
9. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Diabetes Care 2003 26 3160 3167 14578255
10. International Diabetes Federation, The IDF Worldwide Definition of the Metabolic Syndrom 2005
11. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, Bruguera M, Sánchez-Tapias JM, Rodés J, Hepatology 2002 36 986 992 12297848
12. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS-F, Hepatology 2003 38 518 526 12883497 (Pubitemid 36919874)
13. Nonalcoholic fatty liver disease: A review and update. Lewis JR, Mohanty SR, Dig Dis Sci 2010 55 560 578 10.1007/s10620-009-1081-0 20101463
14. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A New Equation to Estimate Glomerular Filtration Rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ann Intern Med 2009 150 9 604 612 10.7326/0003-4819-150-9- 200905050-00006 19414839
15. U.S. Department of Agriculture, Center for Nutrition Policy and Promotion 2008 http://MyPyramid.gov
16. Food and Nutrition Board, Institute of Medicine, Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids,Cholesterol, Protein, and Amino Acids (Macronutrients). [prepublication version] Washington, DC: National Academy Press 2002
17. Nutrition and liver disease. Corish C, Topics Clin Nutr 1997 55 17 20 (Pubitemid 27220098)
18. Factors influencing the development of a hepatitis C exercise protocol: A literature review. Gapinski MA, Zucker DM, Gastroenterol Nurs 2005 28 Suppl 3 10 18
19. Hepatic failure. Shronts E, Fish J, Nutrition Support Dietetics: Core Curriculum Silver Springs, MD: ASPEN Publishers, Gottschlich MM, Matarese LE, Shronts EP, 2 1993 311 326
20. Hepatic failure. Raup SM, Kaproth P, Contemporary Nutrition Support Practice Philadelphia, PA: WB Saunders Company, Matarese LE, Gottschlich MM, 1998 441 446
21. Resting energy expenditure in chronic hepatitis C. Piche T, Schneider SM, Tran A, Benzaken S, Rampal P, Hébuterne X, J Hepatol 2000 33 4 623 627 10.1016/S0168-8278(00)80014-8 11059867
22. Guidelines for nutritional therapy in liver disease. McCullough AJ, Teran JC, Bugianesi E, ASPEN Nutritional Support Practice Manual Silver Springs, MD: American Society for Parenteral and Enteral Nutrition, Klein ES, 1998 1 12 12
23. American Dietetic Association, Dietitians of Canada, Manual of Clinical Dietetics. 6th ed 2000 ADA and DC
24. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial. Heit JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh J, Ann Intern Med 2000 132 853 861 10836911 (Pubitemid 30346847)
25. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Moher D, Schulz KF, Altman D, JAMA 2001 285 1987 1991 10.1001/jama.285.15.1987 11308435 (Pubitemid 32366951)
26. A low carbohydrate as compared with a low-fat diet in severe obesity. Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L, N Engl J Med 2003 348 2074 2081 10.1056/NEJMoa022637 12761364 (Pubitemid 36583302)
27. ROmanian multicentric study of the prevalence of metabolic syndrome-ROMES. Matei C, Pop I, Jurcut R, Suceveanu M, Predescu D, Nechita E, Ionescu P, Ciovica D, Ginghina C, Hellenic J Cardiol 2008 49 303 309 18846919
28. Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey (NHANES III). Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ, Diabetes Res Clin Pract 2007 75 320 326 10.1016/j.diabres.2006.07.008 16919355 (Pubitemid 46074212)
29. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS, Am J Gastroenterol 2003 98 2064 2071 10.1111/j.1572-0241.2003.07640.x 14499789 (Pubitemid 37185807)
30. Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis. Lonardo A, Ballestri S, Adinolfi LE, Violi E, Carulli L, Lombardini S, Scaglioni F, Ricchi M, Ruggiero G, Loria P, Can J Gastroenterol 2009 23 273 278 19373421
31. Metabolic alterations and chronic hepatitis C: treatment strategies. Adinolfi LE, Restivo L, Zampino R, Lonardo A, Loria P, Expert Opin Pharmacother 2011 12 2215 2234 10.1517/14656566.2011.597742 21883025
32. Reduction in weight and cardiovascular disease risk factors in individuals with Type 2 diabetes: one-year results of the look AHEAD trial. Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, Haffner SM, Harrison B, Hill JO, Horton ES, Jakicic J, Jeffery RW, Johnson KC, Kahn S, Kelley DE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montgomery B, Nathan DM, Patricio J, Peters A, Redmon JB, Reeves RS, Ryan DH, Safford M, Van Dorsten B, Wadden TA, Wagenknecht L, Wesche-Thobaben J, Wing RR, Yanovski SZ, Look AHEAD Research Group, Diabetes Care 2007 30 1374 1383 17363746 (Pubitemid 46871141)
33. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Hickman IJ, Clouston AD, Macdonald GA, Purdie DM, Prins JB, Ash S, Jonsson JR, Powell EE, Gut 2002 51 89 94 10.1136/gut.51.1.89 12077098 (Pubitemid 34717750)
34. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, Powell EE, Hepatology 1999 29 1215 1219 10.1002/hep.510290401 10094967 (Pubitemid 29168757)
35. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, Torimura T, Inuzuka S, Sata M, Tanikawa K, J Hepatol 1997 27 103 107 10.1016/S0168-8278(97)80287-5 9252081 (Pubitemid 27357062)
36. Hepatic effects of dietary weight loss in morbidly obese subjects. Andersen T, Gluud C, Franzmann MB, Christoffersen P, J Hepatol 1991 12 224 229 10.1016/0168-8278(91)90942-5 2051001
37. Ultrasonographic fatty liver indicator, a novel score which rules aut NASH and is correlated with metabolic parameters in NAFLD. Ballestri S, Lonardo A, Romagnoli D, Carulli L, Losi L, Day CP, Loria P, Liver Int 2012 32 1242 1252 10.1111/j.1478-3231.2012.02804.x 22520641
38. Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD). Scaglioni F, Marino M, Ciccia S, Procaccini A, Busacchi M, Loria P, Lonardo A, Malavolti M, Battistini NC, Pellegrini M, Carubbi F, Bellentani S, Clin Res Hepatol Gastroenterol 2012 http://www.ncbi.nlm.nih.gov/pubmed/23273500 S2210-7401(12)00328-2
39. Relation of low and moderate intensity exercise with acute mood change in college joggers. Berger BG, Owen DR, Perceptual &Motor Skills 1998 87 611 621 10.2466/pms.1998.87.2.611 23946433
40. Selective effects of acute exercise and breakfast interventions on mood and motivation to eat. Lluch A, Hubert P, King NA, Blundell JE, Physiol Behav 2000 68 515 520 10.1016/S0031-9384(99)00198-5 10713292 (Pubitemid 30129237)